Impact of palliative chemotherapy and best supportive care on overall survival and length of hospitalization in patients with incurable Cancer: a 4-year single institution experience in Japan-Reference-Cited by-同舟云学术

Impact of palliative chemotherapy and best supportive care on overall survival and length of hospitalization in patients with incurable Cancer: a 4-year single institution experience in Japan

Published:2019-06-03 Issue:1 Volume:18 Page:
ISSN:1472-684X
Container-title:BMC Palliative Care
language:en
Short-container-title:BMC Palliat Care

Author:

Murakawa Yasuko,Sakayori Masato,Otsuka Kazunori

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12904-019-0428-3.pdf

Reference41 articles.

1. Browner I, Carducci MA. Palliative chemotherapy: historical perspective, applications, and controversies. Semin Oncol. 2005;32(2):145–55.

2. Hosaka T, Aoki T, Watanabe T, Okuyama T, Kurosawa H. Comorbidity of depression among physically ill patients and its effect on the length of hospital stay. Psychiatry Clin Neuros. 1999;53(4):491–5.

3. Earle CC, Park ER, Lai B, Weeks JC, Ayanian JZ, Block S. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol. 2003;21(6):1133–8.

4. Payne SA. A study of quality of life in cancer patients receiving palliative chemotherapySoc. Sci Med. 1992;35(12):1505–9.

5. Tsuji T. Health-care issues: Japan’s aging society and appropriate countermeasures. Jpn J Nurs Sci. 2007;4(2):71–3.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical impact of the G8 screening tool score on treatment strategy decisions and outcomes among oral squamous cell carcinoma patients aged 75 years or older in Japan;Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology;2024-09

2. High early mortality after percutaneous liver biopsy in metastatic cancer: national analysis;BMJ Supportive & Palliative Care;2024-08-01

3. Absolute lymphocyte count as a biomarker for best supportive care transition in metastatic breast cancer;BMJ Supportive & Palliative Care;2024-06-04

4. The Impact of Palliative Care Consultation on Aggressive Medical Interventions in End-of-life Among Patients with Metastatic Breast Cancer: Insights from the U.S. National Patient Sample;Journal of Palliative Care;2024-05-15

5. Palliative care reduces emergency room visits and total hospital days among patients with metastatic HPB and GI cancers;Scientific Reports;2022-12-06